U.S. Releases Practice Guidelines for Interventions for Diabetics
-
Last Update: 2020-07-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
the American Diabetes Association (ADA) has published practical guidelines for interventional measures such as screening, diagnosis, and treatment of people with diabetesExperts believe the guidelines could improve the prognosis of people with diabetesIt is reported that the topics covered by the practice guide include: diagnosis of diabetes, screening of pre-diabetes and pre-diabetes, screening oftype 2 diabetes inchildren, diagnosis and screening of type 2 diabetes in, intervention in adult type 2 diabetes, self-blood glucose monitoring, glycogenic hemoglobin (A1C) levels, blood sugar targets,dietcontrol, diabetes self-management education (DSME), physical exercise,psychologicalevaluation and care, hypoglycemia,,, and blood
lipidsIn addition, the guidelines cover the use of platelet drugs, smoking cessation, screening and treatment of coronary heart disease, screening and treatment of kidney disease, retinopathy and neurological lesions, foot care, and other special circumstances, such as care for diabetics in emergency cases, confusion, self-management education and support for diabeticpatientsTheof these standards for care is for clinicians, patients, researchers, health care providers, and others involved in diabetes care, treatment objectives, and care evaluation tools, and the standards covered in the guidelines do not exclude the evaluation and treatment of patients by other areas of experts if necessary
, ADA said (Shi Hui)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
![benzyl N-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl}carbamate](https://file.echemi.com/fileManage/upload/goodpicture/20210823/m20210823171124543.jpg)
